₹151.64
2.97 (2.0%) - 12 Jul 2025 04:27 PMBrooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets. As of March 31, 2010, its product portfolio consist of 26 dry powder injections, 31 liquid injections, five tablets and two dry syrups. It manufactures a range of products on third party basis for companies, such as Zydus Cadila, Alembic, Intas, Wockhardt, Medley, Biochem, JB Chemical, PDPL and Sanat. Brooks Laboratories has a range of products catering to critical care segment in parental section, such as Beta Lactum, Cephalosporin, Carbapenems, General Dry powder Injectables and Liquid Injectables. Its Carbapenems products include Inj Ertapenem and Inj Meropenem. Its Liquid Injectables include Inj Nandrolone Decanoate, Inj Aceclofenac and Inj Midazolam.
Industry - Pharmaceuticals & Drugs
* Please refer to the Standalone data if Consolidated financial data for the company is not available.
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED
| All logos and Trademarks registered with their respective owners.
